Helping you comply with the Solvency II regulations as well as optimising your Solvency II balance sheet
Helping you comply with the regulations as well as optimising your Economic Balance Sheet (EBS)
Helping you comply with the regulations as well as optimising your ICS balance sheet

Francis is a Principal Consultant in charge of our insurance practice in Dublin. He has 15 years of experience within the life and non-life (re)insurance industry. His expertise covers the areas of financial reporting, prudential regulation, and actuarial modelling. Francis has worked in both industry and consulting with extensive exposure to Solvency II and BMA-regulated clients and a keen eye on new regulatory developments.
This blog post series covers the draft amendments to the Solvency II Delegated Acts (EU Regulation 2015/35)1 published on 18 July 2025 by the European Commission. Following consultation with industry and professional bodies, the updated Delegated Acts are expected to be approved in Q4 2025.
The process of the Solvency II 2020 review started in February 2019 with the Call for Advice from the European Commission (EC). The previous milestone in the process was on 27 November 2024 when the European Parliament approved changes to the Solvency II Directive 2009/138/EC (Level 1)2. The timelines, key milestones of the Solvency II Review and the approved changes to the Solvency II Directive in 2024 were covered in our previous blog post3.
The changes to the Delegated Acts are aligned to the updates to the Directive and provide additional technical (Level 2) details and guidance for (re)insurance undertakings. The changes to both the Delegated Acts and the Directive will take effect 20 days after their publication in the Official Journal, plus one additional day, resulting in an effective date of 29 January 2027.
The key topics addressed by the Solvency II review are the following:
The proposed amendments to the Delegated Acts address these and other issues across all three pillars of Solvency II as illustrated in the chart below:
In Part 1, we examine the amendments to the calculation of Technical Provisions and Own Funds. Upcoming blogposts in this series will explore the changes to the Solvency Capital Requirement (SCR) and to Pillars II and III, for both solo and group entities.
The key changes affecting Technical Provisions (TPs) are:
We explain each of these changes below.
The risk margin is expected to decrease significantly due to the following proposed changes:
The revised formula introduces a risk tapering factor (λ = 0.96) applied as an exponential adjustment (λ^t). This adjustment declines over time and reaches a floor of 0.5 after 17 years, remaining constant at 0.5 thereafter.
The new risk margin (RM) formula is:

the cost of capital (CoC) was decreased from 6% to 4.75%.
The reduction in cost of capital is intended to help EU insurers keep pace with their UK counterparts after Brexit, although the rate still remains above the 4% applied under the Solvency UK regime. The risk tapering factor is 0.9 for life and 1 for non-life companies in the UK – in contrast with the single factor of 0.96 in Solvency II - with a lower floor of 0.25. This also means that there is no tapering adjustment for non-life companies although it is more relevant for life portfolios with long durations. This change will significantly reduce long-term liabilities, particularly for life insurers, improving capital ratios.
The smoothing (or extrapolation) methodology of yield curves changed with the introduction of the first smoothing point (FSP):
Furthermore, it was clarified that no credit risk adjustment is required for overnight swaps as part of financial instruments used to derive the basic risk-free interest rates.
Phased implementation of the extrapolation of yield curves is allowed for five years between 1 January 2027 and 1 January 2032. The Delegated Act also introduces explicit α-values for the extrapolation transition: 11% for the euro and 40% for the Swedish krona. These will taper linearly to zero by 2032, providing a gradual move from the last liquid point (LLP) toward the ultimate forward rate (UFR).
The amendments of the Solvency II Directive4 approved by the European Parliament in 2024 included changes to the calculation of the volatility adjustment, we covered this in detail in our previous blog post5, namely:
The updated Delegated Acts provide further detail and formulae for the calculation of the volatility adjustment. The update formalises the Country-Specific Spread Risk (CSSR) mechanism, ensuring the VA better reflects persistent spread widening in local markets. It also clarifies treatment for insurers with pegged-currency portfolios, whose reference risk-free rate is tied to the euro.
 The formula for the spread underlying the volatility adjustment was simplified by removing the zero floor, meaning negative spreads will now be included rather than floored at zero. The new formula is:
S = wgov · Sgov  +  wcorp · Scorp
 where w and S denote weights and spreads of government and corporate bonds, respectively. In addition, the denominator for calculating the weights wgov  and wcorp has changed — it is now based only on the total value of bonds, loans, and securitisations in the reference portfolio, rather than all assets.
 Formulae are provided for the calculation of the risk-corrected spread for both government bonds and non-government bonds, loans, and securitisations in the European Economic Area (EEA). Both calculations apply a tiered formula of average spreads capped at 65% and 125% of the long-term average spreads, respectively.
The formula for the Credit Spread Sensitivity Ratio (CSSR) was introduced for each currency as the ratio of PVBP (price value of a basis point) of assets – bonds, loans and securitisations – and best estimate liabilities.
The new rules enable undertakings to invest in more complex, restructured assets - where the cash flows depend on the performance of other underlying assets – with certain conditions.
 These conditions are designed to ensure that the cash flows of the underlying assets are sufficiently predictable and fixed, and that this predictability is preserved and carried through to the restructured assets held in the portfolio.
The condition on repeating risk assessment changed from factual impossibility to legal right. This may lead to shorter contract boundaries for certain protection products where the insurance company has the right to reassess the risk by contract before the end of the term – even if this is currently not done or not feasible to perform in practice.
The proposed amendments require expenses to be projected in line with management’s actual intentions around writing new business, rather than assuming ongoing new business activity by default as under the current going-concern approach. For closed and entities this may result in a higher expense BEL which allows for expected run-off expenses and potentially also expense floors.
The amendments also clarify that expense inflation assumptions should reflect the insurer’s own expectations and experience, rather than relying on a general market index.
This new proportionality measure allows small and non-complex entities to simplify the valuation of immaterial options and guarantees. The regulation defines immaterial as those representing less than 5% of the SCR, which may differ from internal or audit materiality thresholds. Without this provision, entities would otherwise be required to perform a full stochastic calculation of the value of options and guarantees.
New rules require undertakings to avoid overreliance on past events in relation to climate change-related trends.
The rationale for this lies in adverse trends in climate risk in recent years which are not always linear and hence projections based on historic data can be misleading. Instead, EIOPA promotes the use of forward-looking climate risk scenario analysis and projections. This requirement is consistent with EIOPA’s ORSA guidance, reinforcing the need to integrate forward-looking climate scenarios and avoid reliance on purely historical experience.
Although covered in the Pillar II section, the offsetting rules between and across homogeneous risks groups (HRGs) affects the calculation of the BEL. The proposed updates add explicit requirements for offsetting both within and between HRGs, the latter was not permissible earlier. This may lead to a revision of the BEL aggregation methodology and potentially a reduction in the total BEL due to more offsetting.
The updated Delegated Acts clarify several key definitions to improve alignment between prudential and accounting frameworks. New or revised terms include future management actions, expected profit in future fees (EPIFF), and the classification of defaulted and forborne exposures, distributions and foreseeable charges ensuring greater consistency with IFRS 17 terminology.
The key changes affecting Own Funds are:
The conditions for not deducting strategic participations changed, it now requires permission from the supervisory authority. Previously, the condition was that the strategic participation is included in the group solvency calculation using method 1 (consolidation method).
The proposed amendments introduce the accrual method for calculating foreseeable dividends and distributions that form part of the reconciliation reserve. In addition, a new hierarchy is established: foreseeable dividends are determined first by an approved dividend policy, then by an established payout ratio, and finally by the most recent distribution proposal. This structured approach enhances consistency and transparency in the assessment of Own Funds. This hierarchy brings greater predictability and comparability in Own Funds reporting across insurers.
The amount of dividends and distributions have to be formally approved by management or proposed to the relevant body and should be in line with the undertaking’s dividends or distributions policy. If such a policy does not exist or does not provide a prudent basis for foreseeable dividends and distribution, then they should be calculated as a historic average over three years excluding exceptional items.
The proposed amendments also introduce a new provision clarifying that transactions with the same economic effect as repayment or redemption, such as most share buyback unless the bought back shares are used immediately (or within 1 month) to service stock option programs, must be treated accordingly, tightening rules on capital management and preventing artificial inflation of solvency ratios.
The amendments clarify that foreseeable losses arising after the balance sheet date must be recognized prudently in the Own Funds calculation. This measure ensures that the reported solvency positions accurately reflect the undertaking’s current and prospective financial position.
The proposed rules remove the need to calculate a separate SCR for matching adjustment portfolios (MAP) unless they qualify as ring fenced funds. This change allows diversification between MAPs and the rest of the portfolio, replacing the current approach where no such diversification is permitted.
Note that, following Brexit, the only country in the EU with significant use of matching adjustment portfolios is Spain, so this is not relevant for other countries. The rules related to MAPs changed recently as part of the Solvency UK reform recently marking a divergence between the two regimes.
The upcoming amendments to the Solvency II Delegated Acts and Directive aim to modernise the framework and address key gaps identified in the review. Although the changes will not apply until January 2027, regulators expect (re)insurers to start assessing their impact well in advance.
At Finalyse, our actuarial and risk management experts can help you prepare through our comprehensive Solvency II Review Service — a structured, two-phase approach designed to assess your readiness and support implementation.
These phases are supported by:
The Delegated Acts provide detailed (Level 2) rules supporting the Solvency II Directive. The 2025 amendments modernize the framework to address issues like volatility, proportionality for smaller insurers, and incentives for long-term investment.
The updated Delegated Acts are expected to be approved in late 2025 and will become effective on 29 January 2027, 20 days after publication in the Official Journal.
Insurers are encouraged to start impact assessments early, adjust governance and reporting frameworks, and align models with new Solvency II requirements before 2027.
| Finalyse InsuranceFinalyse offers specialized consulting for insurance and pension sectors, focusing on risk management, actuarial modeling, and regulatory compliance. Their services include Solvency II support, IFRS 17 implementation, and climate risk assessments, ensuring robust frameworks and regulatory alignment for institutions. | 

Check out Finalyse Insurance services list that could help your business.
Get to know the people behind our services, feel free to ask them any questions.
Read Finalyse client cases regarding our insurance service offer.
Read Finalyse blog articles regarding our insurance service offer.
Designed to meet regulatory and strategic requirements of the Actuarial and Risk department
Designed to meet regulatory and strategic requirements of the Actuarial and Risk department.
Designed to provide cost-efficient and independent assurance to insurance and reinsurance undertakings
| Finalyse BankingFinalyse leverages 35+ years of banking expertise to guide you through regulatory challenges with tailored risk solutions. | 

Designed to help your Risk Management (Validation/AI Team) department in complying with EU AI Act regulatory requirements
A tool for banks to validate the implementation of RWA calculations and be better prepared for CRR3 in 2025
In 2025, FRTB will become the European norm for Pillar I market risk. Enhanced reporting requirements will also kick in at the start of the year. Are you on track?
| Finalyse ValuationValuing complex products is both costly and demanding, requiring quality data, advanced models, and expert support. Finalyse Valuation Services are tailored to client needs, ensuring transparency and ongoing collaboration. Our experts analyse and reconcile counterparty prices to explain and document any differences. | 

Helping clients to reconcile price disputes
Save time reviewing the reports instead of producing them yourself
Helping institutions to cope with reporting-related requirements
| Finalyse PublicationsDiscover Finalyse writings, written for you by our experienced consultants, read whitepapers, our RegBrief and blog articles to stay ahead of the trends in the Banking, Insurance and Managed Services world | 

Finalyse’s take on risk-mitigation techniques and the regulatory requirements that they address
A regularly updated catalogue of key financial policy changes, focusing on risk management, reporting, governance, accounting, and trading
Read Finalyse whitepapers and research materials on trending subjects
| About FinalyseOur aim is to support our clients incorporating changes and innovations in valuation, risk and compliance. We share the ambition to contribute to a sustainable and resilient financial system. Facing these extraordinary challenges is what drives us every day. | 

| Finalyse CareersUnlock your potential with Finalyse: as risk management pioneers with over 35 years of experience, we provide advisory services and empower clients in making informed decisions. Our mission is to support them in adapting to changes and innovations, contributing to a sustainable and resilient financial system. | 

Get to know our diverse and multicultural teams, committed to bring new ideas
We combine growing fintech expertise, ownership, and a passion for tailored solutions to make a real impact
Discover our three business lines and the expert teams delivering smart, reliable support